MEDCL — Medincell SA Cashflow Statement
0.000.00%
Last trade - 00:00- €441.71m
- €414.93m
- €9.03m
Annual cashflow statement for Medincell SA, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -23.9 | -19 | -24.8 | -32 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 6.55 | 4.92 | 4.29 | 12.4 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.57 | 0.625 | -2.37 | -3.04 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.5 | -12.1 | -21.4 | -21 | — |
| Capital Expenditures | -0.889 | -0.819 | -1.97 | -1.03 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.961 | -0.243 | 1.66 | 2.33 | — |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.072 | -1.06 | -0.316 | 1.3 | — |
| Financing Cash Flow Items | -1.53 | -3.5 | -1.13 | -4.46 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.56 | 47.9 | -0.8 | 1.56 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.91 | 34.7 | -22.5 | -18.1 | — |